• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新一代紫杉烷类化合物的化学和生物学研究进展。

Recent advances in the chemistry and biology of new generation taxoids.

机构信息

Department of Chemistry and Institute of Chemical Biology & Drug Discovery, State University of New York at Stony Brook, Stony Brook, New York 11794-3400, USA.

出版信息

J Nat Prod. 2009 Mar 27;72(3):554-65. doi: 10.1021/np8006556.

DOI:10.1021/np8006556
PMID:19239240
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2727999/
Abstract

Among the numerous chemotherapeutic drugs, paclitaxel and docetaxel are among the most widely used against various types of cancer. However, these drugs cause undesirable side effects as well as drug resistance. Therefore, it is essential to develop "taxane" anticancer agents with better pharmacological properties and improved activity especially against drug-resistant cancers. Several laboratories have performed extensive SAR studies on paclitaxel. Our SAR studies have led to the development of numerous highly potent novel second- and third-generation taxoids with systematic modifications at the C-2, C-10, and C-3' positions. The third-generation taxoids showed virtually no difference in potency against drug-resistant and drug-sensitive cell lines. Some of the new generation taxoids also exhibited excellent cytotoxicity against pancreatic cell lines expressing multidrug-resistant genes. We have also designed taxoids with strategic fluorine incorporation to investigate their effects on the cytotoxicity and the blockage of known metabolic pathways. Furthermore, we have successfully employed computational biology analysis to design novel macrocyclic taxoids to mimic the bioactive conformation of paclitaxel. This account describes our work on the design, synthesis, and biological evaluation of these novel taxoids, which has led to the discovery of very promising candidates for further preclinical studies.

摘要

在众多的化疗药物中,紫杉醇和多西紫杉醇是最广泛用于治疗各种类型癌症的药物之一。然而,这些药物会引起不良的副作用和耐药性。因此,开发具有更好药理性质和更高活性的“紫杉烷”抗癌药物,特别是针对耐药性癌症,是非常重要的。许多实验室对紫杉醇进行了广泛的 SAR 研究。我们的 SAR 研究导致了许多具有系统修饰的 C-2、C-10 和 C-3'位的高活性新型第二代和第三代紫杉烷的开发。第三代紫杉烷对耐药性和敏感性细胞系的活性几乎没有差异。一些新一代紫杉烷对表达多药耐药基因的胰腺细胞系也表现出优异的细胞毒性。我们还设计了具有战略氟化物掺入的紫杉烷,以研究它们对细胞毒性和已知代谢途径阻断的影响。此外,我们还成功地运用计算生物学分析来设计新型的大环紫杉烷,以模拟紫杉醇的生物活性构象。本报告描述了我们在这些新型紫杉烷的设计、合成和生物学评价方面的工作,这些工作发现了非常有前途的候选药物,可进一步进行临床前研究。

相似文献

1
Recent advances in the chemistry and biology of new generation taxoids.新一代紫杉烷类化合物的化学和生物学研究进展。
J Nat Prod. 2009 Mar 27;72(3):554-65. doi: 10.1021/np8006556.
2
Quest for Efficacious Next-Generation Taxoid Anticancer Agents and Their Tumor-Targeted Delivery.探寻高效的下一代紫杉烷类抗癌药物及其肿瘤靶向递送。
J Nat Prod. 2018 Mar 23;81(3):703-721. doi: 10.1021/acs.jnatprod.7b01012. Epub 2018 Feb 22.
3
Recent advances in the strategic incorporation of fluorine into new-generation taxoid anticancer agents.氟在新一代紫杉烷类抗癌药物中的策略性引入的最新进展。
J Fluor Chem. 2023 Apr;267. doi: 10.1016/j.jfluchem.2023.110106. Epub 2023 Feb 21.
4
Design, synthesis and SAR study of Fluorine-containing 3rd-generation taxoids.含氟第三代紫杉烷的设计、合成及构效关系研究。
Bioorg Chem. 2022 Feb;119:105578. doi: 10.1016/j.bioorg.2021.105578. Epub 2021 Dec 23.
5
Recent advances in the new generation taxane anticancer agents.新一代紫杉烷类抗癌药物的最新进展。
Med Chem. 2005 Mar;1(2):125-39. doi: 10.2174/1573406053175292.
6
Design, synthesis and SAR study of 3rd-generation taxoids bearing 3-CH, 3-CFO and 3-CHFO groups at the C2-benzoate position.设计、合成和第三代 taxoids 的 SAR 研究 3-CH,3-CFO 和 3-CHFO 基团在 C2-苯甲酸酯位置。
Bioorg Chem. 2020 Jan;95:103523. doi: 10.1016/j.bioorg.2019.103523. Epub 2019 Dec 20.
7
Chemistry and chemical biology of taxane anticancer agents.紫杉烷类抗癌药物的化学与化学生物学
Chem Rec. 2001;1(3):195-211. doi: 10.1002/tcr.1008.
8
Design, synthesis, and biological evaluation of new-generation taxoids.新一代紫杉烷类化合物的设计、合成及生物学评价
J Med Chem. 2008 Jun 12;51(11):3203-21. doi: 10.1021/jm800086e. Epub 2008 May 9.
9
Medicinal chemistry and chemical biology of new generation taxane antitumor agents.新一代紫杉烷类抗肿瘤药物的药物化学与化学生物学
IUBMB Life. 2002 Apr-May;53(4-5):269-74. doi: 10.1080/15216540212658.
10
Design, synthesis, and biological evaluation of novel C14-C3'BzN-linked macrocyclic taxoids.新型C14-C3'BzN连接的大环紫杉烷类化合物的设计、合成及生物学评价
J Org Chem. 2008 Dec 19;73(24):9584-93. doi: 10.1021/jo801713q.

引用本文的文献

1
Third-generation taxanes SB-T-121605 and SB-T-121606 are effective in pancreatic ductal adenocarcinoma.第三代紫杉烷类药物SB-T-121605和SB-T-121606对胰腺导管腺癌有效。
iScience. 2024 Jan 26;27(2):109044. doi: 10.1016/j.isci.2024.109044. eCollection 2024 Feb 16.
2
Anticancer regimens containing third generation taxanes SB-T-121605 and SB-T-121606 are highly effective in resistant ovarian carcinoma model.包含第三代紫杉烷类药物SB-T-121605和SB-T-121606的抗癌方案在耐药性卵巢癌模型中具有高效性。
Front Pharmacol. 2022 Nov 9;13:971905. doi: 10.3389/fphar.2022.971905. eCollection 2022.
3
Strategies for the drug discovery and development of taxane anticancer therapeutics.紫杉烷类抗癌治疗药物的药物发现和开发策略。
Expert Opin Drug Discov. 2022 Nov;17(11):1193-1207. doi: 10.1080/17460441.2022.2131766. Epub 2022 Oct 14.
4
TM2, a novel semi-synthetic taxoid, exerts anti-MDR activity in NSCLC by inhibiting P-gp function and stabilizing microtubule polymerization.TM2,一种新型半合成紫杉烷类化合物,通过抑制 P-糖蛋白功能和稳定微管聚合来发挥抗多药耐药性(MDR)活性。
Apoptosis. 2022 Dec;27(11-12):1015-1030. doi: 10.1007/s10495-022-01767-4. Epub 2022 Sep 15.
5
The Role of TRIP6, ABCC3 and CPS1 Expression in Resistance of Ovarian Cancer to Taxanes.TRIP6、ABCC3 和 CPS1 表达在卵巢癌细胞对紫杉烷类药物耐药中的作用。
Int J Mol Sci. 2021 Dec 22;23(1):73. doi: 10.3390/ijms23010073.
6
Design, synthesis and SAR study of Fluorine-containing 3rd-generation taxoids.含氟第三代紫杉烷的设计、合成及构效关系研究。
Bioorg Chem. 2022 Feb;119:105578. doi: 10.1016/j.bioorg.2021.105578. Epub 2021 Dec 23.
7
Regulatory role of the transforming growth factor-β signaling pathway in the drug resistance of gastrointestinal cancers.转化生长因子-β信号通路在胃肠道癌耐药中的调控作用
World J Gastrointest Oncol. 2021 Nov 15;13(11):1648-1667. doi: 10.4251/wjgo.v13.i11.1648.
8
Nab-paclitaxel promotes the cancer-immunity cycle as a potential immunomodulator.纳米白蛋白结合型紫杉醇作为一种潜在的免疫调节剂可促进癌症免疫循环。
Am J Cancer Res. 2021 Jul 15;11(7):3445-3460. eCollection 2021.
9
Palladium-Catalyzed Synthesis and Anticancer Activity of Paclitaxel-Dehydroepiandrosterone Hybrids.钯催化的紫杉醇 - 脱氢表雄酮杂合物的合成及其抗癌活性
ACS Omega. 2020 Mar 9;5(10):5589-5600. doi: 10.1021/acsomega.0c00558. eCollection 2020 Mar 17.
10
Recent progress in the strategic incorporation of fluorine into medicinally active compounds.将氟战略性地引入药用活性化合物的最新进展。
J Fluor Chem. 2019 Jan;217:29-40. doi: 10.1016/j.jfluchem.2018.11.002. Epub 2018 Nov 3.

本文引用的文献

1
Syntheses and Structure-Activity Relationships of Novel 3'-Difluoromethyl and 3'-Trifluoromethyl-Taxoids.新型3'-二氟甲基和3'-三氟甲基紫杉烷类化合物的合成及其构效关系
J Fluor Chem. 2008;129(9):817-828. doi: 10.1016/j.jfluchem.2008.05.013.
2
Design, synthesis, and biological evaluation of novel C14-C3'BzN-linked macrocyclic taxoids.新型C14-C3'BzN连接的大环紫杉烷类化合物的设计、合成及生物学评价
J Org Chem. 2008 Dec 19;73(24):9584-93. doi: 10.1021/jo801713q.
3
Design, synthesis, and biological evaluation of new-generation taxoids.新一代紫杉烷类化合物的设计、合成及生物学评价
J Med Chem. 2008 Jun 12;51(11):3203-21. doi: 10.1021/jm800086e. Epub 2008 May 9.
4
MDR1/P-glycoprotein and MRP-1 drug efflux pumps in pancreatic carcinoma.胰腺癌中的多药耐药蛋白1/ P-糖蛋白和多药耐药相关蛋白1药物外排泵
Anticancer Res. 2007 Jul-Aug;27(4B):2115-20.
5
Evaluation of the tubulin-bound paclitaxel conformation: synthesis, biology, and SAR studies of C-4 to C-3' bridged paclitaxel analogues.微管蛋白结合紫杉醇构象的评估:C-4至C-3'桥连紫杉醇类似物的合成、生物学及构效关系研究
J Med Chem. 2007 Feb 22;50(4):713-25. doi: 10.1021/jm061071x. Epub 2007 Jan 31.
6
Rotational-echo double-resonance NMR distance measurements for the tubulin-bound Paclitaxel conformation.用于微管蛋白结合紫杉醇构象的旋转回波双共振核磁共振距离测量。
J Am Chem Soc. 2007 Jan 17;129(2):361-70. doi: 10.1021/ja0656604.
7
Novel C2-C3' N-peptide linked macrocyclic taxoids. Part 2: synthesis and biological activities of docetaxel analogues with a peptide side chain at C2 and their macrocyclic derivatives.新型C2-C3' N-肽连接的大环紫杉烷类化合物。第2部分:C2位带有肽侧链的多西他赛类似物及其大环衍生物的合成与生物活性
Bioorg Med Chem. 2007 Jan 1;15(1):563-74. doi: 10.1016/j.bmc.2006.09.030. Epub 2006 Oct 24.
8
Metabolism of new-generation taxanes in human, pig, minipig and rat liver microsomes.新一代紫杉烷类在人、猪、小型猪和大鼠肝脏微粒体中的代谢。
Xenobiotica. 2006 Sep;36(9):772-92. doi: 10.1080/00498250600829220.
9
Cancer statistics, 2006.2006年癌症统计数据。
CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30. doi: 10.3322/canjclin.56.2.106.
10
Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinase.c-Jun氨基末端激酶逆转癌细胞中P-糖蛋白介导的多药耐药性
Cancer Res. 2006 Jan 1;66(1):445-52. doi: 10.1158/0008-5472.CAN-05-1779.